Macrophage derived signalling regulates negatively the megakaryocyte compartment

V I Landoni1, M Vermeulen, N Van Rooijen

  • 1Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina.

Insights

Depleting macrophages enhances megakaryocyte progenitor cells (MK-CFU) and thrombopoietin (TPO) levels. Macrophage signaling negatively regulates megakaryocytopoiesis in the bone marrow and spleen.

Area of Science:

  • Hematology
  • Cell Biology
  • Immunology

Background:

  • Megakaryocytopoiesis, the production of platelets from stem cells, occurs in the bone marrow and spleen microenvironments.
  • Accessory cells, including macrophages, play regulatory roles in megakaryocytopoiesis.
  • Previous studies indicated that macrophage depletion enhances megakaryocytopoiesis and thrombocytopoiesis.

Purpose of the Study:

  • To investigate the impact of macrophage depletion on megakaryocyte progenitor cells (MK-CFU) and thrombopoietin (TPO) levels.
  • To explore the correlation between MK-CFU, plasma TPO, and TPO transcription levels following macrophage depletion.
  • To elucidate the role of bone marrow and spleen macrophages in regulating the megakaryocyte compartment.

Main Methods:

  • Macrophage depletion was induced using liposomal clodronate (LIP-CLOD) in mice.
  • Quantification of megakaryocyte progenitor cells (MK-CFU) in bone marrow and spleen.
  • Measurement of plasma thrombopoietin (TPO) levels over time.
  • Analysis of TPO transcription levels in the liver and spleen.

Main Results:

  • LIP-CLOD treatment significantly increased MK-CFU in both bone marrow and spleen.
  • Plasma TPO concentrations showed a 1.5-fold and 1.3-fold increase at 12 and 24 hours post-treatment, respectively.
  • TPO gene regulation was observed in the liver and spleen, with transcriptional upregulation correlating with increased protein synthesis only upon effective macrophage removal.

Conclusions:

  • Macrophage depletion leads to an increase in megakaryocyte progenitor cells and thrombopoietin levels.
  • Bone marrow and spleen macrophages negatively regulate megakaryocytopoiesis through signaling pathways.
  • Targeting macrophages may represent a therapeutic strategy to modulate platelet production.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Autocrine Signaling01:01

Autocrine Signaling

Autocrine signaling is one of the many signaling mechanisms that function inside multicellular organisms to carry out intercellular communication. In this type of signaling mechanism, the same cell that secretes an extracellular signaling molecule also expresses the receptors to bind and respond to that signaling molecule.
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...